Mineralys Therapeutics (NASDAQ:MLYS) Sets New 52-Week Low at $12.76

Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Rating) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $12.76 and last traded at $13.10, with a volume of 16849 shares trading hands. The stock had previously closed at $13.56. Wall Street Analyst Weigh In MLYS has been […]

Related Keywords

United States ,America ,Stifel Nicolaus ,Nasdaq ,Wells Fargo Company ,Mineralys Therapeutics Inc ,Mineralys Therapeutics Company Profile ,Credit Suisse Group ,Securities Exchange Commission ,Mineralys Therapeutics ,Get Rating ,Suisse Group ,Therapeutics Stock Down ,Scott Levy ,Hbm Healthcare Investments ,Exchange Commission ,Therapeutics Inc ,Mineralys Therapeutics Daily ,Nasdaq Mlys ,Fmlys ,Medical ,Stocks ,Technicals ,